Levothyroxine sodium and Eloxatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levothyroxine sodium (levothyroxine sodium) and Eloxatin (oxaliplatin). Common drug interactions include oxygen saturation decreased among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Levothyroxine sodium and Eloxatin. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Levothyroxine sodium?

Levothyroxine sodium has active ingredients of levothyroxine sodium. It is often used in hypothyroidism. eHealthMe is studying from 129,814 Levothyroxine sodium users. Check the latest studies of Levothyroxine sodium.

What is Eloxatin?

Eloxatin has active ingredients of oxaliplatin. eHealthMe is studying from 7,092 Eloxatin users. Check the latest studies of Eloxatin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

28 people who take Levothyroxine sodium and Eloxatin together, and have interactions are studied.

Levothyroxine sodium and Eloxatin drug interactions.

What are the common drug interactions of Levothyroxine Sodium and Eloxatin, by gender? *:

female:

  1. Oxygen saturation decreased
  2. Abdominal pain
  3. Renal failure (kidney dysfunction)
  4. Acute myocardial infarction (acute heart attack)
  5. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  6. Atelectasis (partial or complete collapse of the lung)
  7. Cardiac failure congestive
  8. Dizziness
  9. Hypotension (abnormally low blood pressure)
  10. Hypoxia (low oxygen in tissues)

male:

  1. Abdominal pain
  2. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  3. Septic shock (shock due to blood infection)
  4. Acute myocardial infarction (acute heart attack)
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the common drug interactions of Levothyroxine Sodium and Eloxatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Abdominal pain
  2. Blood bilirubin increased
  3. Hypokalaemia (low potassium)
  4. Vomiting

60+:

  1. Renal failure (kidney dysfunction)
  2. Dyspnoea (difficult or laboured respiration)
  3. Pruritus (severe itching of the skin)
  4. Vomiting
  5. Cytolytic hepatitis (dissolution or destruction of a liver cell)
  6. Dehydration (dryness resulting from the removal of water)
  7. Fall
  8. Flushing (the warm, red condition of human skin)
  9. Haemoglobin decreased
  10. Neutropenic sepsis (whole body infection is caused by a condition in which the number of white blood cells (called neutrophils) in the blood is low. neutrophils help the body to fight infection)

What are the existing conditions these people have? *

  1. Colon Cancer: 8 people, 28.57%
  2. Rectal Cancer (cancer of rectum): 7 people, 25.00%
  3. Stress And Anxiety: 3 people, 10.71%
  4. Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 3 people, 10.71%
  5. Colon Cancer Stage Iii: 3 people, 10.71%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 10.71%
  7. Metastases To Lung (cancer spreads to lung): 2 people, 7.14%
  8. Metastases To Liver (cancer spreads to liver): 2 people, 7.14%
  9. Abdominal Pain: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Levothyroxine sodium and Eloxatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Levothyroxine sodium and Eloxatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Levothyroxine sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Eloxatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levothyroxine sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eloxatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on levothyroxine sodium and oxaliplatin (the active ingredients of Levothyroxine sodium and Eloxatin, respectively), and Levothyroxine sodium and Eloxatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: